drugset / Trial / NCT06723015
Tau PET Outcomes With Anti-amyloid Immunotherapies
Non-randomizedParallel-groupOpen-labelOther
Summary
This is an imaging study of patients with mild Alzheimer's disease receiving amyloid-targeting therapy and under the care of neurologists at Mayo Clinic in Rochester, MN.
Timeline
- Start
- 2025-11-04
- Primary completion
- 2028-08
- Completion
- 2028-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Flortaucipir F18 | Diagnostic / imaging agent | 370 mbq | — |